/wuxi-biologics-and-aravive-form-strategic-collaboration-to-develop-novel-high-affinity-bispecific-antibodies-targeting-cancer-and-fibrosis-using-the-wuxibody-platform/ 提供端到端一站式解决方案 Fri, 17 Sep 2021 05:58:24 +0000 hourly 1